SPYRAL HTN-ON MED renal denervation study did not meet primary endpoint

The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall and ablate the nerves controlling vasodilation, so the artery can be propped in the fully open position.

The SPYRAL HTN-ON MED renal denervation trial failed to show that renal denervation was superior to sham control at improving ambulatory blood pressure (ABPM), but that might have been due to patient lifestyle changes during COVID-19.

FDA Commissioner Robert Califf calls on cardiology to address health inequities and combat misinformation

U.S. Food and Drug Administration Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association (AHA) last week about the need for doctors and health systems to step up to address two major problems - misinformation and health disparities.
U.S. FDA Commissioner Robert Califf, MD, a cardiologist, spoke at the opening session of the American Heart Association (AHA) 2022 meeting about the need for doctors and health systems to step up to address two major problems - misinformation and health disparities.

FDA Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association about the need to step up and address two major problems in the American healthcare system.